Scott Glazer, MD
Procedural Dermatology · Buffalo Grove, ILNPI 1770587206
Payments from drug & device makers
Across 541 payments — averaging $85.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$30K
- E.r. Squibb & Sons, L.L.C.$9K
- EPI Health, LLC$2K
- Johnson & Johnson$897
- Sanofi$718
- Revance Therapeutics, Inc.$545
- plus $4K from 27 others
What the payments were for
- Consulting fees$2,9008%
- Speaking & faculty fees$26,28670%
- Food & beverage$8,23322%
- Education$3181%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 254 | $30,284 |
| E.r. Squibb & Sons, L.L.C. | 11 | $8,897 |
| EPI Health, LLC | 2 | $1,534 |
| Johnson & Johnson | 66 | $897 |
| Sanofi | 31 | $718 |
| Revance Therapeutics, Inc. | 9 | $545 |
| Sun Pharmaceutical Industries Inc. | 23 | $437 |
| Lilly USA, LLC | 17 | $395 |
| UCB, Inc. | 11 | $334 |
| Galderma Laboratories, L.p. | 15 | $318 |
| Amgen | 16 | $305 |
| Regeneron Healthcare Solutions, Inc. | 9 | $255 |
| Merz North America, Inc. | 3 | $181 |
| Arcutis Biotherapeutics, Inc. | 8 | $165 |
| LEO Pharma Inc. | 7 | $149 |
| Pfizer | 9 | $138 |
| Novartis | 7 | $137 |
| Mayne Pharma Commercial LLC | 9 | $110 |
| Boehringer Ingelheim | 5 | $90 |
| Genentech USA, Inc. | 5 | $88 |
| Incyte Corporation | 3 | $76 |
| Dermavant Sciences, Inc. | 3 | $57 |
| Mallinckrodt Hospital Products Inc. | 2 | $54 |
| Kyowa Kirin, Inc. | 2 | $42 |
| Smith+Nephew | 2 | $38 |
| Verrica Pharmaceuticals Inc. | 1 | $29 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $28 |
| Organon | 3 | $27 |
| Organogenesis Inc. | 1 | $27 |
| Janssen Scientific Affairs, LLC | 2 | $27 |
| VYNE Pharmaceuticals Inc. | 1 | $24 |
| Biofrontera Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few procedural dermatology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 19 | $128,629 |
| Dupixent PenDupilumab | 13 | $48,389 |
| Betamethasone Dipropionate | 144 | $5,007 |
| Clobetasol Propionate | 88 | $3,201 |
| Minoxidil | 241 | $3,019 |
| Doxycycline Hyclate | 101 | $2,552 |
| Ketoconazole | 128 | $2,290 |
| Triamcinolone Acetonide | 229 | $2,064 |
| Mometasone Furoate | 104 | $1,441 |
| Metronidazole | 14 | $1,303 |
| ValacyclovirValacyclovir Hcl | 44 | $693 |
| Minocycline Hcl | 47 | $626 |
| Clindamycin Phosphate | 15 | $388 |
| Doxepin Hcl | 20 | $387 |
| Fluticasone Propionate | 12 | $358 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Buffalo Grove
- Keith KozenyBuffalo Grove$178K
- Michael FretzinBuffalo Grove$22K
- Ashish BhatiaItasca$640K
- David OthmanChicago$131K
- Amy BrodskyRockford$21K
- Kent TaulbeeBloomington$544
- Valeria FugaliChicago$456
- Charles ZugermanChicago$420
- David FretzinPark Ridge$207
- Raymond VahlWorth$136
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.